Animal drugs, feeds, and related products: Ractopamine,
[Federal Register: November 23, 2007 (Volume 72, Number 225)]
[Rules and Regulations]
[Page 65666-65667]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23no07-6]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
New Animal Drugs For Use in Animal Feeds; Ractopamine
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health. The supplemental NADA provides for an increased level of monensin in two-way combination Type B and Type C medicated feeds containing ractopamine hydrochloride and monensin for cattle fed in confinement for slaughter.
DATES: This rule is effective November 23, 2007.
FOR FURTHER INFORMATION CONTACT: Daniel A. Benz, Center for Veterinary Medicine (HFV-126), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0223, e-mail: daniel.benz@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Elanco Animal Health, A Division of Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, filed a supplement to NADA 141 225 that provides for use of OPTAFLEXX (ractopamine hydrochloride) and RUMENSIN (monensin USP) Type A medicated articles to make dry and liquid two-way combination medicated feeds for cattle fed in confinement for slaughter. The supplemental NADA provides for an increased level of monensin in combination Type B and Type C medicated feeds. The supplemental NADA is approved as of October 30, 2007, and the regulations in 21 CFR 558.500 are amended to reflect the approval.
In accordance with the freedom of information provisions of 21 CFR part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
The agency has determined under 21 CFR 25.33(a)(2) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor environmental impact statement is required.
This rule does not meet the definition of ``rule'' in 5 U.S.C. 804(3)(A) because it is a rule of ``particular applicability.'' Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
List of Subjects in 21 CFR Part 558
Animal drugs, Animal feeds.
0 Therefore, under the Federal Food, Drug, and Cosmetic Act and under the authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:
PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
0 1. The authority citation for 21 CFR part 558 continues to read as follows:
Authority: 21 U.S.C. 360b, 371.
[[Page 65667]]
0 2. In Sec. 558.500, in the table in paragraph (e)(2), revise paragraphs (e)(2)(ii) and (e)(2)(vii) to read as follows:
Sec. 558.500 Ractopamine.
* * * * *
(e) * * *
(2) * * *
Ractopamine Combination Indications for grams/ton grams/ton
use
Limitations Sponsor
* * * * * * *
(ii) 8.2 to Monensin 10 to Cattle fed in As in
000986 24.6
40 to provide confinement for paragraph 0.14 to 0.42 mg slaughter: As (e)(2)(i) monensin/lb of in paragraph of this body weight, (e)(2)(i) of section; depending on this section; see severity of for prevention paragraph coccidiosis and control of Sec. Sec. challenge, up coccidiosis due to 480 mg/head/ to Eimeria
558.355(d) day
bovis and E of this zuernii.
chapter.
* * * * * * *
(vii) 9.8 to Monensin 10 to Cattle fed in As in
000986 24.6
40 to provide confinement for paragraph 0.14 to 0.42 mg slaughter: As (e)(2)(vi) monensin/lb of in paragraph of this body weight, (e)(2)(vi) of section; depending on this section; see severity of for prevention paragraph coccidiosis and control of Sec. Sec. challenge, up coccidiosis due to 480 mg/head/ to Eimeria
558.355(d) day
bovis and E of this zuernii.
chapter.
* * * * * * *
Dated: November 8, 2007. Bernadette Dunham, Deputy Director, Center for Veterinary Medicine.
[FR Doc. E7-22882 Filed 11-21-07; 8:45 am]
BILLING CODE 4160-01-S
